查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1599251

兽医免疫诊断市场：按产品、动物、技术和最终用户 - 全球预测 2025-2030

Veterinary Immunodiagnostics Market by Product (Analyzers, Consumables), Animal (Companion, Livestock), Technology, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年兽医免疫诊断市场价值为35.8亿美元，预计到2024年将达到39.1亿美元，复合年增长率为9.59%，到2030年将达到68.1亿美元。

动物免疫诊断市场包括检测和测量动物特异性免疫反应的诊断测试和技术。该市场范围从常规兽医实践到专业研究，为疾病诊断、疫苗评估以及动物健康和生物安全监测提供重要工具。宠物拥有量的迅速增加、牲畜健康管理需求以及通用感染疾病的出现推动了对兽医免疫诊断的需求。应用范围从血清学测试和酵素结合免疫吸附检测法(ELISA) 到先进的分子诊断，以确保动物健康和生产力。最终用户主要是兽医医院、研究实验室和畜牧农民，他们都依赖这些诊断来进行快速、准确的评估，以帮助健康管理和研究。

主要市场统计
基准年[2023] 35.8亿美元
预计年份 [2024] 39.1亿美元
预测年份 [2030] 68.1亿美元
复合年增长率（%） 9.59%

市场成长主要受到诊断准确性和效率方面技术进步以及对动物健康问题认识不断提高的影响。此外，增加对先进诊断测试的监管支援正在推动市场需求。兽医环境中对即时现场结果的需求为开发快速照护现场诊断解决方案提供了潜在的商机。为了利用这一点，建议投资携带式诊断设备以及与资料管理和疾病追踪数位平台的整合。

然而，市场面临一些限制，例如与先进诊断技术相关的高成本以及缺乏能够执行和解释复杂测试的熟练人员。此外，监管障碍可能会减缓新诊断方法向市场的推出。应对这些挑战需要对成本降低策略和培训计画进行策略性投资，以提高技能水准。

有许多创新领域，包括允许同时测试多种疾病状态的多重检测的研究，以及能够实现更具预测性的动物健康管理的基于人工智慧的诊断方法。总体而言，由于技术进步对创新和高效解决方案的需求不断增长以及人们对预防性动物保健的兴趣日益浓厚，兽医免疫诊断市场显示出巨大的潜力。

市场动态：快速发展的兽医免疫诊断市场的关键市场洞察

供需的动态交互作用正在改变兽医免疫诊断市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 感染疾病和通用感染疾病的盛行率增加
    • 政府动物保健倡议
    • 改善经济国家的兽医医疗设施
  • 市场限制因素
    • 免疫诊断测试成本上升
  • 市场机会
    • 动物免疫诊断药物的研究进展
    • 单株抗体和重组抗原的潜力
  • 市场挑战
    • 关于疫苗无效的问题

波特五力：开拓兽医免疫诊断市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更具弹性的市场地位。

PESTLE分析：了解外部对兽医免疫诊断市场的影响

外部宏观环境因素在塑造兽医免疫诊断市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解动物免疫诊断试剂市场竞争状况

兽医免疫诊断市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵兽医免疫诊断市场供应商的绩效评估

FPNV定位矩阵是评估兽医免疫诊断市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘兽医免疫诊断市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对动物免疫诊断市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 感染疾病和通用感染疾病的盛行率增加
      • 政府关于动物保健的倡议
      • 改善经济中的兽医护理设施
    • 抑制因素
      • 免疫诊断测试高成本
    • 机会
      • 动物免疫诊断药物的研究进展
      • 单株抗体和重组抗原的潜力
    • 任务
      • 关于疫苗无效的问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章兽医免疫诊断市场：副产品

  • 分析仪
  • 消耗品

第七章动物免疫诊断市场：依动物分类

  • 同胞
  • 家畜

第八章动物免疫诊断市场：依技术分类

  • 酵素连结免疫吸附试验
  • 免疫检测
  • 快速测试

第九章兽医免疫诊断市场：依最终用户分类

  • 医院
  • 照护现场

第10章：北美和南美兽医免疫诊断试剂市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太兽医免疫诊断市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东、非洲兽用免疫诊断试剂市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Agrolabo SpA
  • Biogal Galed Labs
  • BioMerieux SA
  • BioNote, Inc.
  • Fassisi GmbH
  • FUJIFILM Holdings Corporation
  • Heska Corporation
  • IDEXX Laboratories, Inc.
  • IDvet
  • Neogen Corporation
  • Precision Biosensor Inc.
  • Randox Laboratories, Ltd.
  • Shenzhen Bioeasy Biotechnology Co., Ltd.
  • Shenzhen Mindray Animal Medical Technology Co., Ltd.
  • SKYER, Inc.
  • Skyla Corporation
  • Thermo Fisher Scientific Inc.
  • Vimian Group AB
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-AD517FAA8B82

The Veterinary Immunodiagnostics Market was valued at USD 3.58 billion in 2023, expected to reach USD 3.91 billion in 2024, and is projected to grow at a CAGR of 9.59%, to USD 6.81 billion by 2030.

The veterinary immunodiagnostics market encompasses diagnostic tests and technologies that detect and measure specific immune responses in animals. This market's scope extends from routine veterinary practice to specialized research contexts, providing tools essential for disease diagnosis, vaccine evaluations, and monitoring animal health and biosecurity. The necessity for veterinary immunodiagnostics is driven by burgeoning pet ownership, livestock health management needs, and the emergence of zoonotic diseases. Applications range from serological tests and enzyme-linked immunosorbent assays (ELISAs) to advanced molecular diagnostics employed to ensure animal health and productivity. End-users predominantly include veterinary hospitals, research laboratories, and livestock farms, each relying on these diagnostics for quick, accurate assessments that inform health management or research studies.

KEY MARKET STATISTICS
Base Year [2023] USD 3.58 billion
Estimated Year [2024] USD 3.91 billion
Forecast Year [2030] USD 6.81 billion
CAGR (%) 9.59%

Market growth is predominantly influenced by technological advancements in diagnostic accuracy and efficiency, alongside the growing awareness of animal health issues. Additionally, increasing regulatory support for advanced diagnostic testing fuels market demand. Potential opportunities await in the development of rapid, point-of-care diagnostic solutions, driven by the necessity for immediate and on-site results in veterinary settings. To capitalize on this, investments in portable diagnostics and integration with digital platforms for data management and disease tracking are recommended.

However, the market faces limitations such as high costs associated with advanced diagnostic technologies and a shortage of skilled personnel able to run and interpret complex tests. Furthermore, regulatory hurdles can delay the introduction of novel diagnostics in the market. Addressing these challenges requires strategic investments in cost-reduction strategies and training programs to enhance skill levels.

Innovation is fertile in areas like multiplex assays, which allow for the simultaneous testing of multiple conditions, and furthering research into AI-driven diagnostics for more predictive animal health management. Overall, the veterinary immunodiagnostics market shows robust potential, driven by a rising demand for innovative, efficient solutions underpinned by technological advancement and increasing focus on preventive animal healthcare.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary Immunodiagnostics Market

The Veterinary Immunodiagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of infectious diseases and zoonotic diseases
    • Government initiatives for animal healthcare
    • Improving veterinary care facilities in economies
  • Market Restraints
    • High cost of immunodiagnostics tests
  • Market Opportunities
    • Advances in veterinary immunodiagnostics
    • Potential for monoclonal antibodies and recombinant antigens
  • Market Challenges
    • Issues relating to ineffectiveness of vaccines

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary Immunodiagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary Immunodiagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary Immunodiagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary Immunodiagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary Immunodiagnostics Market

A detailed market share analysis in the Veterinary Immunodiagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary Immunodiagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary Immunodiagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary Immunodiagnostics Market

A strategic analysis of the Veterinary Immunodiagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Immunodiagnostics Market, highlighting leading vendors and their innovative profiles. These include Agrolabo S.p.A., Biogal Galed Labs, BioMerieux S.A., BioNote, Inc., Fassisi GmbH, FUJIFILM Holdings Corporation, Heska Corporation, IDEXX Laboratories, Inc., IDvet, Neogen Corporation, Precision Biosensor Inc., Randox Laboratories, Ltd., Shenzhen Bioeasy Biotechnology Co., Ltd., Shenzhen Mindray Animal Medical Technology Co., Ltd., SKYER, Inc., Skyla Corporation, Thermo Fisher Scientific Inc., Vimian Group AB, Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Immunodiagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Analyzers and Consumables.
  • Based on Animal, market is studied across Companion and Livestock.
  • Based on Technology, market is studied across ELISA, Radioimmunoassay, and Rapid Tests.
  • Based on End User, market is studied across Hospital and Point-of-Care.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of infectious diseases and zoonotic diseases
      • 5.1.1.2. Government initiatives for animal healthcare
      • 5.1.1.3. Improving veterinary care facilities in economies
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of immunodiagnostics tests
    • 5.1.3. Opportunities
      • 5.1.3.1. Advances in veterinary immunodiagnostics
      • 5.1.3.2. Potential for monoclonal antibodies and recombinant antigens
    • 5.1.4. Challenges
      • 5.1.4.1. Issues relating to ineffectiveness of vaccines
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Veterinary Immunodiagnostics Market, by Product

  • 6.1. Introduction
  • 6.2. Analyzers
  • 6.3. Consumables

7. Veterinary Immunodiagnostics Market, by Animal

  • 7.1. Introduction
  • 7.2. Companion
  • 7.3. Livestock

8. Veterinary Immunodiagnostics Market, by Technology

  • 8.1. Introduction
  • 8.2. ELISA
  • 8.3. Radioimmunoassay
  • 8.4. Rapid Tests

9. Veterinary Immunodiagnostics Market, by End User

  • 9.1. Introduction
  • 9.2. Hospital
  • 9.3. Point-of-Care

10. Americas Veterinary Immunodiagnostics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Veterinary Immunodiagnostics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Veterinary Immunodiagnostics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agrolabo S.p.A.
  • 2. Biogal Galed Labs
  • 3. BioMerieux S.A.
  • 4. BioNote, Inc.
  • 5. Fassisi GmbH
  • 6. FUJIFILM Holdings Corporation
  • 7. Heska Corporation
  • 8. IDEXX Laboratories, Inc.
  • 9. IDvet
  • 10. Neogen Corporation
  • 11. Precision Biosensor Inc.
  • 12. Randox Laboratories, Ltd.
  • 13. Shenzhen Bioeasy Biotechnology Co., Ltd.
  • 14. Shenzhen Mindray Animal Medical Technology Co., Ltd.
  • 15. SKYER, Inc.
  • 16. Skyla Corporation
  • 17. Thermo Fisher Scientific Inc.
  • 18. Vimian Group AB
  • 19. Virbac S.A.
  • 20. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. VETERINARY IMMUNODIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. VETERINARY IMMUNODIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. VETERINARY IMMUNODIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VETERINARY IMMUNODIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VETERINARY IMMUNODIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RAPID TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. VETERINARY IMMUNODIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 189. VETERINARY IMMUNODIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023